Navigation Links
Professor John Shine wins 2010 Prime Minister's Prize for Science
Date:11/17/2010

Professor John Shine AO FAA, Executive Director of Sydney's Garvan Institute of Medical Research, received the 2010 Prime Minister's Prize for Science, the nation's most highly respected award for scientific achievement, in Parliament House tonight.

The prize is awarded for 'an outstanding specific achievement or series of related achievements in any area of science advancing human welfare or benefiting society'.

Professor Shine is world-renowned for a series of discoveries he made between 1975 and 1985 that furthered our understanding of how genes are turned into the proteins that do the work in cells. He also developed sophisticated gene cloning techniques that helped revolutionise the world of biotechnology.

As an honours student at Canberra's Australian National University (ANU), he uncovered the mechanism behind termination of protein synthesis in mammals, insects and bacteria. A discovery he describes as "not very sexy", it nonetheless showed us how ribosomes tiny structures in cells that translate genetic code into functional proteins know exactly where to snip a long and complex string of amino acids to release a protein into a cell.

Perhaps best known for the 'Shine-Dalgarno Sequence', his PhD discovery that also bears the name of his supervisor at ANU, Lyn Dalgarno, Shine found the sequence in messenger RNA (the working copy of a gene) that ribosomes recognise to initiate and control the efficiency of protein synthesis in bacteria. A landmark finding, today's sophisticated genome annotation software still uses it to help identify start points of protein synthesis.

Shine was the first person to clone a human hormone gene human placental lactogen and played a major role in cloning the insulin and growth hormone genes. In the process, he developed several ingenious methods of 'cloning', or extricating single genes (a few thousand out of 3.2 billion nucleotides on each strand of DNA) for replication in bacteria.

Professor Shine became Director of Garvan in 1990, when gene cloning was starting to have a big impact in medical research. Since then he has held countless influential scientific advisory roles, including Chairman of the National Health and Medical Research Council (NHMRC) from 2003-2006 and Vice President (Biological Sciences) Australian Academy of Science from 2002-2007.

"Winning the Prime Minister's Science Prize is an enormous honour," said Professor Shine.

"Most pleasing though is that the Prize itself is a recognition of the importance that government and the community places on science and its role in the social and economic well being of our country."


'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Research Australia
Source:Eurekalert

Related medicine news :

1. CancerCare names Jefferson professor Physician of the Year
2. Professor Cesare Montecucco to receive the 2011 Paul Ehrlich and Ludwig Darmstaedter Prize
3. UT professor defines play, discovers even turtles need recess
4. Virginia Tech professor discovers new TB pathogen
5. Drug to treat alcoholism goal of UH professors research
6. K-State professors book is first to explore Two-Spirit literature in Northwest native groups
7. Louisiana Tech kinesiology professor receives national editorial excellence award
8. WPI computer science professor receives HP Labs Innovation Research Award
9. Linguistics professor examines manufacturers prescription drug websites
10. NJIT professor heads panel studying sudden car acceleration
11. "How Facebook Makes Lonely People Even Lonelier" Revealed by Distinguished University of Chicago Professor in Interview with Brian Vaszily on IntenseExperiences.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... Pittsburgh, PA (PRWEB) , ... May 26, 2016 ... ... transplantation, and one that has a significant negative impact on long-term patient survival, ... to date. The results, published online this week in the Journal of Thoracic ...
(Date:5/26/2016)... ... May 26, 2016 , ... Dr. James ... Fighting Blindness, Long Island Chapter on June 4, 2016, 1:30-3:30 pm at the ... founder of Retina Group of New York , is a Board Certified ...
(Date:5/26/2016)... ... May 26, 2016 , ... Leadership of Life ... announced the organization has earned its ISO 13485 certification, indicating the company’s quality ... all rules and policies associated with ISO quality standard 13485. , BSI ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... offering campers a multitude of activities from daily practices, arts & crafts, discussions, ... Camp Directors Amber East-D’Anna and Christy Evans have combined backgrounds in kids’ yoga, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Power Systems, a leading developer ... Instructor Certification Course in Stoughton, Massachusetts. The course was led by Power Systems’ ... 8 hour interactive course to qualify participants as certified PowerWave trainers. , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... 25, 2016 ReportsnReports.com adds ... report that provides an overview on therapeutic pipeline ... various stages, therapeutics assessment by drug target, mechanism ... molecule type, along with latest updates, and featured ... players involved in the therapeutic development for Chronic ...
(Date:5/24/2016)... 2016   , Study ... overall bowel cleansing and superiority in , ... of the ascending colon ... Norgine B.V. today announced new positive data from the ... bowel preparation) versus standard 2 litre PEG with ascorbate. The study ...
(Date:5/24/2016)... , May 24, 2016 Celsion ... drug development company, today provided an update on ... escalating clinical trial combining GEN-1, the Company,s DNA-based ... treatment of newly-diagnosed patients with advanced ovarian cancer ... debulking surgery.  GEN-1 is an IL-12 DNA plasmid ...
Breaking Medicine Technology: